Amendment #7 to H3944

Hallucinogenic Substances

Representatives Muradian of Grafton and Whelan of Brewster move to amend the bill by inserting at the end thereof the following new section:-

“SECTION XX. Section 31 of chapter 94C of the General Laws, as appearing in the 2014 Official Edition, is hereby amended in class C by inserting after subsection (f) the following:

(g)  Unless specifically excepted or listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following hallucinogenic substances, or which contains any of their salts, isomers, and salt of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

(1)  4-methyl-N-ethylcathinone ("4-MEC")

(2) 4-methyl-alpha-pyrrolidinopropiophenone ("4-MePPP")

(3) 2-(methylamino)-1-phenylpentan-1-one ("pentedrone")

(4) 3,4-methylenedioxy-N,N-dimethylcathinone (“dimethylone”)

(5)  1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one ("pentylone")

(6)  4-fluoro-N-methylcathinone ("4-FMC")

(7)  3-fluoro-N-methylcathinone ("3-FMC")

(8)  1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one ("naphyrone")

(9) alpha-pyrrolidinobutiophenone ("α-PBP")

(10) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(fluorobenzyl)-1H-indazole-3-carboxamide (“AB-Fubinaca”)

(11) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (“AB-Pinaca”)

(12) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-   carboxamide (“AB-Chminaca”)

(13) [1-(fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (“THJ-2201”)

(14) (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (“UR-144”)

(15) [1-(fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (“XLR-11”)

(16) quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (“PB-22”)

(17) quinolin-8-yl 1-(fluoropentyl)-1H-indole-3-carboxylate (“Fluoro-PB-22”)

(18) N-(1-amino-3,3-dimethyl-1-oxobutan-2¬-yl)-1-pentyl-1H-indazole-3-carboxamide     (“ADB-Pinaca”)

(19) N-(1-Adamantyl)-1-pentyl-1H¬-indazole-3-carboxamide (“APINACA”)”.